These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Synergistic effect of a factor Xa inhibitor, TAK-442, and antiplatelet agents on whole blood coagulation and arterial thrombosis in rats. Konishi N; Hiroe K; Kawamura M Thromb Res; 2010 Aug; 126(2):124-9. PubMed ID: 20452654 [TBL] [Abstract][Full Text] [Related]
24. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation. Geisler T; Anders N; Paterok M; Langer H; Stellos K; Lindemann S; Herdeg C; May AE; Gawaz M Diabetes Care; 2007 Feb; 30(2):372-4. PubMed ID: 17259513 [No Abstract] [Full Text] [Related]
25. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease. Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138 [No Abstract] [Full Text] [Related]
26. Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy. Tsoumani ME; Tatsidou PT; Ntalas IV; Goudevenos JA; Tselepis AD Platelets; 2016 Dec; 27(8):812-820. PubMed ID: 27337147 [TBL] [Abstract][Full Text] [Related]
27. Variability of response to antiplatelet therapy: what should we do next? Shantsila E; Lip GY Fundam Clin Pharmacol; 2009 Feb; 23(1):19-22. PubMed ID: 19267768 [No Abstract] [Full Text] [Related]
28. New thoughts on strategies for modulating platelet function through the inhibition of surface receptors. Nurden AT Haemostasis; 1996 Oct; 26 Suppl 4():78-88. PubMed ID: 8979114 [TBL] [Abstract][Full Text] [Related]
29. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel. van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417 [No Abstract] [Full Text] [Related]
30. Platelet reactivity and stent thrombosis: still some issues to solve. Perez de Prado A; Cuellas C; Diego A; de Miguel A; Fernandez-Vazquez F J Am Coll Cardiol; 2009 Aug; 54(7):666-7; author reply 667-8. PubMed ID: 19660707 [No Abstract] [Full Text] [Related]
31. Impact of aspirin and clopidogrel interruption on platelet function in patients undergoing major vascular surgery. Le Manach Y; Kahn D; Bachelot-Loza C; Le Sache F; Smadja DM; Remones V; Loriot MA; Coriat P; Gaussem P PLoS One; 2014; 9(8):e104491. PubMed ID: 25141121 [TBL] [Abstract][Full Text] [Related]
32. PlaCor PRT measurement of shear-activated platelet aggregate formation in stable patients treated with single and dual antiplatelet therapy. Godino C; Pavon AG; Mangieri A; Viani GM; Galaverna S; Spartera M; Chieffo A; Cappelletti A; Margonato A; Colombo A Platelets; 2014; 25(5):337-42. PubMed ID: 23971989 [TBL] [Abstract][Full Text] [Related]
33. 24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis. Würtz M; Hvas AM; Jensen LO; Kaltoft AK; Tilsted HH; Kristensen SD; Grove EL Int J Cardiol; 2014 Aug; 175(2):274-9. PubMed ID: 24861258 [TBL] [Abstract][Full Text] [Related]
34. Platelet aggregation and the risk of stent thrombosis or bleeding in elective percutaneous coronary intervention patients. Kukula K; Klopotowski M; Kunicki P; Jamiolkowski J; Debski A; Bekta P; Chmielak Z; Witkowski A Blood Coagul Fibrinolysis; 2017 Jul; 28(5):383-388. PubMed ID: 28009648 [TBL] [Abstract][Full Text] [Related]
35. [Difficulties in evaluating the efficacy of antiplatelet therapy in clinical practice]. Buriachkovskaia LI; Uchitel' IA; Sumarokov AV; Popov EG Ter Arkh; 2009; 81(5):41-7. PubMed ID: 19537585 [TBL] [Abstract][Full Text] [Related]